EverSource Wealth Advisors’s Enovis ENOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.1K Sell
343
-531
-61% -$12.5K ﹤0.01% 3108
2026
Q1
$19.9K Buy
874
+288
+49% +$6.81K ﹤0.01% 2507
2025
Q4
$15.6K Buy
586
+39
+7% +$1.15K ﹤0.01% 2554
2025
Q3
$16.6K Sell
547
-724
-57% -$22K ﹤0.01% 2494
2025
Q2
$39.9K Buy
1,271
+707
+125% +$23.4K ﹤0.01% 1770
2025
Q1
$21.6K Buy
564
+492
+683% +$20.9K ﹤0.01% 1650
2024
Q4
$3.16K Buy
72
+29
+67% +$1.27K ﹤0.01% 2537
2024
Q3
$1.85K Hold
43
﹤0.01% 2573
2024
Q2
$2.05K Sell
43
-89
-67% -$4.62K ﹤0.01% 2542
2024
Q1
$7.29K Buy
132
+91
+222% +$5.45K ﹤0.01% 1851
2023
Q4
$2.3K Buy
41
+22
+116% +$1.1K ﹤0.01% 2130
2023
Q3
$1K Sell
19
-27
-59% -$1.57K ﹤0.01% 2219
2023
Q2
$2.95K Sell
46
-29
-39% -$1.65K ﹤0.01% 1924
2023
Q1
$4.01K Buy
+75
New +$4.35K ﹤0.01% 1719
2022
Q3
Sell
-907
Closed -$50K 2004
2022
Q2
$50K Buy
+907
New +$58.5K 0.01% 628

Other funds holding ENOV

EverSource Wealth Advisors's ENOV Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Enovis (ENOV) stake by 61% in Q2 2026, selling an estimated $12.5K and leaving 343 shares worth $7.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3108.

EverSource Wealth Advisors first reported a position in ENOV in Q2 2022 and has held it in 15 quarters since. The position peaked at $50K in Q2 2022. 251 funds tracked by Wall St. Rank hold ENOV as of Q2 2026.

  • EverSource Wealth Advisors held 343 shares of Enovis worth $7.1K as of Q2 2026.
  • EverSource Wealth Advisors sold 531 Enovis shares in Q2 2026, an estimated $12.5K.
  • Enovis made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3108 holding.
  • EverSource Wealth Advisors first reported a position in Enovis in Q2 2022 and has held it in 15 quarters since.
  • EverSource Wealth Advisors's Enovis position peaked at $50K in Q2 2022.
  • 251 funds tracked by Wall St. Rank held Enovis as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.